Who
Margo Heath-Chiozzi
SVP of Regulatory Affairs
Company insider
Files Form 4 as: SVP of Regulatory Affairs, Celldex Therapeutics.
In numbers
- Trades disclosed
- 32
- Buys
- 1
- Sells
- 4
- Bought
- $3,010
- Sold
- $3.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Oct 2017
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —95,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —95,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —82,000 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —82,000 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,289 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —58,369 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $57K6,289 at $9.02 | filing |
| 3 Jun 2024filed 5 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $606K58,369 at $10.38 | filing |
| 3 Jun 2024filed 5 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $2.0M58,369 at $33.65 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —29,068 at $0.00 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,043 at $0.00 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,608 at $0.00 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $81K29,068 at $2.78 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $18K2,043 at $9.02 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $27K2,608 at $10.38 | filing |
| 30 May 2024filed 3 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $1.3M38,719 at $34.07 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —77,000 at $0.00 | filing |
| 8 Dec 2021filed 10 Dec 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —600 at $0.00 | filing |
| 8 Dec 2021filed 10 Dec 2021 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $1,668600 at $2.78 | filing |
News
No headline names them, or the companies they trade most, lately.